CalcMyPeptide
Clinical / PharmaceuticalAlso known as: DDAVP, Minirin, 1-desamino-8-D-arginine vasopressin

Desmopressin

Synthetic analogue of vasopressin (ADH) with enhanced antidiuretic potency and minimal pressor activity — FDA-approved for diabetes insipidus, nocturnal enuresis, and hemophilia A.

Half-Life
3 hours
Dose Range
10-40 mcg/day (intranasal) or 0.1-0.4 mg oral
Frequency
1-3× daily
Vial Sizes
N/A (oral)

🔬 Mechanism of Action

Desmopressin is a synthetic analogue of vasopressin (arginine vasopressin, AVP) with two key modifications: deamination at position 1 (enhancing antidiuretic potency 10-fold and eliminating pressor activity) and substitution of D-arginine at position 8 (extending half-life by resisting enzymatic degradation). It is a selective V2 receptor agonist that increases cyclic AMP in renal collecting duct principal cells, driving aquaporin-2 channel insertion into the apical membrane. This dramatically increases water reabsorption, concentrating urine and reducing output. In hemophilia A and von Willebrand disease, desmopressin releases endothelial stores of factor VIII and von Willebrand factor via V2-mediated Weibel-Palade body exocytosis.

Source: PMID: 3527577

📜Background & History

Desmopressin (DDAVP) is among the most widely prescribed peptide drugs globally. Developed in 1967 by modifying natural vasopressin, it solved the problem of vasopressin's short half-life and blood pressure effects. Used daily by millions of patients with diabetes insipidus and nocturnal enuresis. Also used pre-operatively in mild hemophilia A to boost factor VIII levels without transfusion.

🎯 Research Use Cases

  • Central diabetes insipidus
  • Nocturnal enuresis
  • Hemophilia A
  • Von Willebrand disease Type 1

💉 Dosing Protocol

Typical Dose10-40 mcg/day (intranasal) or 0.1-0.4 mg oral
Frequency1-3× daily
Half-Life3 hours

⚠️Safety & Considerations

Hyponatremia is the most serious risk — fluid intake must be restricted during use. Contraindicated in habitual/psychogenic polydipsia and hyponatremia-prone conditions. Monitor serum sodium. Not for use in nephrogenic diabetes insipidus.

Interactions & Contraindications

Avoid concurrent NSAIDs (increase ADH effect/hyponatremia risk). Carbamazepine, chlorpropamide, and SSRIs may potentiate antidiuretic effect. Restrict fluid intake during use.

🔗Synergies & Common Stacks

Desmopressin is the synthetic, clinically superior analogue of vasopressin — they are never combined but represent the same receptor pathway.

📊 Dosing Quick Reference

Desmopressin— Dosing Guide
Dose Range
10-40 mcg/day (intranasal) or 0.1-0.4 mg oral
Half-Life
3 hours
Frequency
1-3× daily
Route
Oral
Clinical / Pharmaceuticalcalcmypeptide.com

Frequently Asked Questions

What is desmopressin used for?
FDA-approved for central diabetes insipidus, primary nocturnal enuresis (bedwetting) in children/adults, and to boost clotting factors in hemophilia A and von Willebrand disease Type 1.
How is desmopressin different from vasopressin?
Desmopressin has 10× greater antidiuretic potency, virtually no vasopressor (blood pressure) effect, and a much longer half-life (3 hours vs 10-20 minutes). This makes it clinically safer for chronic use.